Solaris Energy Infrastructure Inc. Class A Common Stock vs TransMedics Group Inc — how do they compare? Solaris Energy Infrastructure Inc. Class A Common Stock trades at $68.36 (market cap $5.12B), while TransMedics Group Inc trades at $75.46 (market cap $2.74B). The key difference: Solaris Energy Infrastructure Inc. Class A Common Stock is the larger of the two by market cap, and Solaris Energy Infrastructure Inc. Class A Common Stock pays a 0.62% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Solaris Energy Infrastructure Inc. Class A Common Stock for 0 Days and TransMedics Group Inc for 24 Days on average.
| SEI | TMDX | |
|---|---|---|
Market Cap | $5.12B | $2.74B |
Volume | 2,532,496 | 1,025,926 |
Sector | Energy | Health |
52-Week High | $82.88 | $150.42 |
52-Week Low | $40.64 | $61.99 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $6.81B | $3.14B |
Dividend Yield | 0.62% | — |
Signals from Pluang's Aura AI — not financial advice
SEI (Solaris Energy Infrastructure) trades at $77.83, down 1.83% today, but maintains strong analyst support with 9 unanimous buy ratings and a $100.56 consensus price target. The stock shows positive momentum with three consecutive quarterly earnings beats and projected revenue growth from $622M in 2025 to $762M in 2026. Recent technical analysis indicates neutral signals with support at $76 and resistance at $79.
The outlook remains positive given strong earnings performance and expansion initiatives, though elevated valuation ratios (P/E of 98.52) and significant debt issuance ($1.25B notes) present risks. The upcoming Q3 2026 earnings report on October 21 will be crucial for validating growth trajectory amid energy sector volatility.
TMDX trades at $79.14, up 1.23% on the day, but faces a bearish technical outlook with recent earnings misses in Q1 and Q2 2026. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Recent news highlights insider buying and a new CFO appointment, alongside multiple legal investigations into fiduciary duties.
The stock presents a mixed outlook; analyst consensus is bullish with a $99.63 price target, but near-term risks include earnings volatility, legal scrutiny, and a declining net cash flow trend. Investors should weigh solid fundamentals against execution and sentiment risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Solaris Energy Infrastructure, Inc. provides mobile power generation, control, and distribution equipment and logistics equipment for managing raw materials at well sites, operating through its Solaris Power Solutions and Solaris Logistics Solutions segments for data center, energy, commercial, and industrial customers.
Read more on SEI →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →